Abstract:60 Background: Cholangiocarcinoma (CCA) is a highly heterogeneous cancer with a poor prognosis. Previous multiplex profiling have been partly identified molecular features of CCA but the underpinnings of CCA’s development, tumor microenvironment (TME) and therapeutic resistance remain largely unknown. Our objective was to characterise genomic/transcriptomic/epigenetic landscapes of CCA aiming to establish therapeutic associated molecular classification. Methods: We profiled 450 untreated CCA with various anatomical subtypes from multiple centers with whole-genome sequencing (WGS), whole-exome sequencing (WES), RNA sequencing, whole-genome bisulfite sequencing (WGBS) and protein immunohistochemistry and performed an integrated analysis as well as clinical-pathological characteristics to identify the molecular determinants, developing a classifier for clinical-molecular prognostic classification and predicting responsiveness of immune checkpoint blockade therapy. Results: Integrative clustering defined 4 CCA subtypes (C1-C4) with distinct clinical-pathological features, TME characteristics, putative therapeutics and prognoses. Then, a 160-gene classifier was created, and this classifier was able to classify the vast majority of CCA cases into the C1-C4 subtypes and was verified to be valuable for guiding clinical treatment. Patients with C3 characteristics had the best prognosis and exhibited higher responsiveness to immune checkpoint blockade therapy than others (75% vs 15%). Moreover, we demonstrated that the CpG island methylator phenotype (CIMP) could serve as an indicator of immunocyte infiltration in the TME of CCA. SOS1 and ATP2B1 were identified as potential new driver genes and significant prognostic biomarkers of CCA. Conclusions: Our studies yield insights into the heterogeneity and clinical-molecular classification of CCA and could aid in the establishment of diagnostic and individualized therapeutic strategies.

Unraveling the heterogeneity of cholangiocarcinoma and identifying biomarkers and therapeutic strategies with single-cell sequencing technology

Advances in single-cell sequencing technology in the field of hepatocellular carcinoma

Single-cell sequencing technology in tumor research

Single-cell analysis technologies for cancer research: from tumor-specific single cell discovery to cancer therapy

Dissecting cellular heterogeneity and intercellular communication in cholangiocarcinoma: implications for individualized therapeutic strategies

Single-Cell Sequencing Technology in Oncology: Applications for Clinical Therapies and Research

Deciphering cell-cell interactions and communication in the tumor microenvironment and unraveling intratumoral genetic heterogeneity via single-cell genomic sequencing

Single-cell sequencing and its applications in bladder cancer

Application of Single-Cell Sequencing Technology in Research on Colorectal Cancer

Single-cell sequencing: a promising approach for uncovering the mechanisms of tumor metastasis

Understanding Initiation and Progression of Hepatocellular Carcinoma Through Single Cell Sequencing.

Single-cell sequencing technologies in bladder cancer research: Applications and challenges

Single-cell sequencing technology in colorectal cancer: a new technology to disclose the tumor heterogeneity and target precise treatment

Single-cell RNA Sequencing in Cancer: Applications, Advances, and Emerging Challenges

The Application of Single-Cell Sequencing in Pancreatic Neoplasm: Analysis, Diagnosis and Treatment

Single-cell transcriptome sequencing reveals heterogeneity of gastric cancer: progress and prospects

Advances in single-cell RNA sequencing and its applications in cancer research

Multi-omics characterization of cholangiocarcinoma and association with prognostic and therapeutic molecular subtypes.

Single cell RNA sequencing for breast cancer: present and future

Unraveling the landscape of non-melanoma skin cancer through single-cell RNA sequencing technology

Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers